Walle-Hansen, Marte M.
Hagberg, Guri
Myrstad, Marius
Berge, Trygve
Vigen, Thea
Ihle-Hansen, Hege
Thommessen, Bente
Ariansen, Inger
Lyngbakken, Magnus N.
Røsjø, Helge
Rønning, Ole M.
Beyer, Mona K.
Tveit, Arnljot
Ihle-Hansen, Håkon
Funding for this research was provided by:
Vestre Viken Hospital Trust
Article History
Received: 16 May 2025
Accepted: 14 August 2025
First Online: 9 October 2025
Declarations
:
: The ACE 1950 Study has been approved by the Regional Committee for Medical and Health Research Ethics in Norway (reference number 2011/1475). The study is preregistered and adheres to the Declaration of Helsinki. An informed consent was signed by all participants who enrolled in the study.
: Not applicable.
: M.M. has received lecture fees from AstraZeneca, Bayer, Boehringer-Ingelheim, Bristol Myers Squibb, MSD, and Pfizer. For the remaining authors none were declared.